Ad is loading...
CLRPF
Price
$4.61
Change
-$0.14 (-2.95%)
Updated
Nov 15 closing price
DOSEF
Price
$0.43
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
Ad is loading...

CLRPF vs DOSEF

Header iconCLRPF vs DOSEF Comparison
Open Charts CLRPF vs DOSEFBanner chart's image
Clarity Pharmaceuticals
Price$4.61
Change-$0.14 (-2.95%)
Volume$21.37K
CapitalizationN/A
Doseology Sciences
Price$0.43
Change-$0.00 (-0.00%)
Volume$200
CapitalizationN/A
CLRPF vs DOSEF Comparison Chart
Loading...
View a ticker or compare two or three
VS
CLRPF vs. DOSEF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLRPF is a Buy and DOSEF is a Buy.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (CLRPF: $4.61 vs. DOSEF: $0.43)
Brand notoriety: CLRPF and DOSEF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLRPF: 335% vs. DOSEF: 31%
Market capitalization -- CLRPF: $1.48B vs. DOSEF: $625.86K
CLRPF [@Biotechnology] is valued at $1.48B. DOSEF’s [@Biotechnology] market capitalization is $625.86K. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLRPF’s FA Score shows that 0 FA rating(s) are green whileDOSEF’s FA Score has 0 green FA rating(s).

  • CLRPF’s FA Score: 0 green, 5 red.
  • DOSEF’s FA Score: 0 green, 5 red.
According to our system of comparison, DOSEF is a better buy in the long-term than CLRPF.

Price Growth

CLRPF (@Biotechnology) experienced а -2.95% price change this week, while DOSEF (@Biotechnology) price change was -18.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
CLRPF($1.48B) has a higher market cap than DOSEF($626K). CLRPF YTD gains are higher at: 257.364 vs. DOSEF (91.373).
CLRPFDOSEFCLRPF / DOSEF
Capitalization1.48B626K237,061%
EBITDAN/A-1.3M-
Gain YTD257.36491.373282%
P/E RatioN/AN/A-
RevenueN/A104K-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYFNX90.800.31
+0.34%
Rydex Financial Services A
ESMAX15.40-0.12
-0.77%
Invesco EQV Euro Small Company A
JANIX29.19-0.52
-1.75%
Janus Henderson Triton D
CMLIX49.62-1.04
-2.05%
Congress Large Cap Growth Institutional
AGRCX31.83-0.92
-2.81%
AB Growth C

CLRPF and

Correlation & Price change

A.I.dvisor tells us that CLRPF and SBHMY have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLRPF and SBHMY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLRPF
1D Price
Change %
CLRPF100%
-2.95%
SBHMY - CLRPF
24%
Poorly correlated
N/A
BOLD - CLRPF
23%
Poorly correlated
-7.10%
HEPA - CLRPF
22%
Poorly correlated
+2.26%
AKBA - CLRPF
21%
Poorly correlated
-3.76%
DOSEF - CLRPF
12%
Poorly correlated
N/A
More

DOSEF and

Correlation & Price change

A.I.dvisor tells us that DOSEF and MNPR have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DOSEF and MNPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DOSEF
1D Price
Change %
DOSEF100%
N/A
MNPR - DOSEF
24%
Poorly correlated
-0.77%
AKRO - DOSEF
23%
Poorly correlated
-5.61%
SGMT - DOSEF
21%
Poorly correlated
-8.69%
ADAG - DOSEF
21%
Poorly correlated
-6.90%
CLRPF - DOSEF
12%
Poorly correlated
-2.95%
More